NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AllRock Bio

AllRock Bio

Private
Natick, MassachusettsHealthcare & Life Scienceshttps://allrockbio.com/

Last Round

Series A

Sep 16, 2025

Est. Valuation

$67M

Total Funding Raised

$50M

Company Overview

AllRock Bio is a biotechnology company developing therapies for cardiopulmonary and fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, E-commerce

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverybiotechbiochemical reagentsresearch chemicalssmall molecule therapeuticsclinical stage biotechlife science researchclinical developmentmolecular biologylab suppliespharma R&Dbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AllRock Bio Comps

Public and private peers based on sector, stage, and business model.

AllRock Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AllRock Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2025

Key People

Founding team and executive leadership

Catherine J. Pearce

CEO And Founder

Founding Team

Andrea Ledford

Chief Financial Officer

Executive Team

AllRock Bio Investors

Notable investors and investment history

AllRock Bio investors
InvestorRounds
Westlake Village BiopartnersSeries A
Versant VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2025

    Grew 240% QoQ from 5 to 17 employees.

  • Oct 21, 2025

    Grew 750% QoQ, from 2 to 17 employees.

AllRock Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AllRock Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AllRock Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts
Employee Range21
Year Founded2024
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.